SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Vinh-Hung V, Verschraegen C. Breast-conserving surgery with or without radiotherapy: pooled-analysis for risks of ipsilateral breast tumor recurrence and mortality. J Natl Cancer Inst. 2004; 96: 115121.
  • 2
    Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005; 366: 20872106.
  • 3
    Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. Lancet. 2000; 355: 17571770.
  • 4
    Cuzick J, Stewart H, Rutqvist L, et al. Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol. 1994; 12: 447453.
  • 5
    Rutqvist LE, Johansson H. Mortality by laterality of the primary tumour among 55,000 breast cancer patients from the Swedish Cancer Registry. Br J Cancer. 1990; 61: 866868.
  • 6
    Paszat LF, Mackillop WJ, Groome PA, Boyd C, Schulze K, Holowaty E. Mortality from myocardial infarction after adjuvant radiotherapy for breast cancer in the Surveillance, Epidemiology, and End Results cancer registries. J Clin Oncol. 1998; 16: 26252631.
  • 7
    Harris EE, Correa C, Hwang WT, et al. Late cardiac mortality and morbidity in early-stage breast cancer patients after breast-conservation treatment. J Clin Oncol. 2006; 24: 41004106.
  • 8
    Hooning MJ, Botma A, Aleman BM, et al. Long-term risk of cardiovascular disease in 10-year survivors of breast cancer. J Natl Cancer Inst. 2007; 99: 365375.
  • 9
    Giordano SH, Kuo YF, Freeman JL, Buchholz TA, Hortobagyi GN, Goodwin JS. Risk of cardiac death after adjuvant radiotherapy for breast cancer. J Natl Cancer Inst. 2005; 97: 419424.
  • 10
    Hojris I, Overgaard M, Christensen JJ, Overgaard J. Morbidity and mortality of ischaemic heart disease in high-risk breast-cancer patients after adjuvant postmastectomy systemic treatment with or without radiotherapy: analysis of DBCG 82b and 82c randomised trials. Radiotherapy Committee of the Danish Breast Cancer Cooperative Group. Lancet. 1999; 354: 14251430.
  • 11
    Hooning MJ, Aleman BMP, Klijn JGM, van Leeuwen FE. Cardiovascular mortality following breast cancer treatment. Eur J Cancer. 2004; 2( Suppl): 140 Abstract.
  • 12
    Nixon AJ, Manola J, Gelman R, et al. No long-term increase in cardiac-related mortality after breast-conserving surgery and radiation therapy using modern techniques. J Clin Oncol. 1998; 16: 13741379.
  • 13
    Patt DA, Goodwin JS, Kuo YF, et al. Cardiac morbidity of adjuvant radiotherapy for breast cancer. J Clin Oncol. 2005; 23: 74757482.
  • 14
    Marks LB, Yu X, Prosnitz RG, et al. The incidence and functional consequences of RT-associated cardiac perfusion defects. Int J Radiat Oncol Biol Phys. 2005; 63: 214223.
  • 15
    Gyenes G, Fornander T, Carlens P, Glas U, Rutqvist LE. Myocardial damage in breast cancer patients treated with adjuvant radiotherapy: a prospective study. Int J Radiat Oncol Biol Phys. 1996; 36: 899905.
  • 16
    Seddon B, Cook A, Gothard L, et al. Detection of defects in myocardial perfusion imaging in patients with early breast cancer treated with radiotherapy. Radiother Oncol. 2002; 64: 5363.
  • 17
    Marks LB, Yu X, Zhou S, et al. The impact of irradiated left ventricular volume on the incidence of radiation-induced cardiac perfusion changes. [abstract]. Int J Radiat Oncol Biol Phys. 2003; 57( 2 suppl): S129.
  • 18
    Marks LB, Prosnitz RG, Hardenbergh PH, et al. Functional consequences of radiation (RT)-induced perfusion changes in patients with left-sided breast cancer. Int J Radiat Oncol Biol Phys. 2002; 54( 2 suppl): 34.
  • 19
    Yu X, Prosnitz RR, Zhou S, et al. Symptomatic cardiac events following radiation therapy for left-sided breast cancer: possible association with radiation therapy-induced changes in regional perfusion. Clin Breast Cancer. 2003; 4: 193197.
  • 20
    Sailer SL, Chaney EL, Rosenman JG, Sherouse GW, Tepper JE. Treatment planning at the University of North Carolina at Chapel Hill. Semin Radiat Oncol. 1992; 2: 267273.
  • 21
    Jones RH, Borges-Neto S, Potts JM. Simultaneous measurement of myocardial perfusion and ventricular function during exercise from a single injection of technetium-99m sestamibi in coronary artery disease. Am J Cardiol. 1990; 66: 68E71E.
  • 22
    Borges-Neto S, Coleman RE, Jones RH. Perfusion and function at rest and treadmill exercise using technetium-99m-sestamibi: comparison of one- and two-day protocols in normal volunteers. J Nucl Med. 1990; 31: 11281132.
  • 23
    Borges-Neto S, Shaw LJ, Kesler KL, et al. Prediction of severe coronary artery disease by combined rest and exercise radionuclide angiocardiography and tomographic perfusion imaging with technetium 99m-labeled sestamibi: a comparison with clinical and electrocardiographic data. J Nucl Cardiol. 1997; 4: 189194.
  • 24
    Evans ES, Prosnitz RG, Yu X, et al. Impact of patient-specific factors, irradiated left ventricular volume, and treatment set-up errors on the development of myocardial perfusion defects after radiation therapy for left-sided breast cancer. Int J Radiat Oncol Biol Phys. 2006; 66: 11251134.
  • 25
    Hojris I, Sand NP, Andersen J, Rehling M, Overgaard M. Myocardial perfusion imaging in breast cancer patients treated with or without post-mastectomy radiotherapy. Radiother Oncol. 2000; 55: 163172.
  • 26
    Woodward WA, Strom EA, McNeese MD, et al. Cardiovascular death and second nonbreast cancer malignancy after postmastectomy radiation and doxorubicin-based chemotherapy. Int J Radiat Oncol Biol Phys. 2003; 57: 327335.
  • 27
    Gustavsson A, Bendahl PO, Cwikiel M, Eskilsson J, Thapper KL, Pahlm O. No serious late cardiac effects after adjuvant radiotherapy following mastectomy in premenopausal women with early breast cancer. Int J Radiat Oncol Biol Phys. 1999; 43: 745754.
  • 28
    Cowen D, Gonzague-Casabianca L, Brenot-Rossi I, et al. Thallium-201 perfusion scintigraphy in the evaluation of late myocardial damage in left-side breast cancer treated with adjuvant radiotherapy. Int J Radiat Oncol Biol Phys. 1998; 41: 809815.
  • 29
    Gyenes G, Fornander T, Carlens P, Rutqvist LE. Morbidity of ischemic heart disease in early breast cancer 15–20 years after adjuvant radiotherapy. Int J Radiat Oncol Bio Phys. 1994; 28: 12351241.
  • 30
    Borges-Neto S, Shaw LK, Tuttle RH, et al. Incremental prognostic power of single-photon emission computed tomographic myocardial perfusion imaging in patients with known or suspected coronary artery disease. Am J Cardiol. 2005; 95: 182188.
  • 31
    Prosnitz RG, Evans E, Zhou S, et al. Objective versus subjective assessment of single photon emission computed tomography (SPECT) cardiac perfusion scans to assess for radiation therapy (RT)-induced cardiac injury. Int J Radiat Oncol Biol Phys. 2005; 63: S3S4.